Other study has shown that increased IGFBP7 also may remodel the tumor microenvironment and promote the progression of esophageal squamous cell carcinoma by activating the transforming growth factor-β1/SMAD signaling pathway (Li et al., 2022). Here, IGFBP7 is linked to neoplasm.